Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insmed (INSM) Shares Outstanding (Weighted Average) (2016 - 2026)

Insmed's Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $215.5 million for Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) rose 19.14% to $215.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $215.5 million through Mar 2026, up 19.14% year-over-year, with the annual reading at $199.0 million for FY2025, 21.32% up from the prior year.
  • Shares Outstanding (Weighted Average) came in at $215.5 million for Q1 2026, up from $199.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $215.5 million in Q1 2026 to a low of $118.9 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $148.5 million (2024), against an average of $156.1 million.
  • Year-over-year, Shares Outstanding (Weighted Average) rose 8.84% in 2022 and then skyrocketed 33.17% in 2025.
  • Insmed's Shares Outstanding (Weighted Average) stood at $123.0 million in 2022, then increased by 14.14% to $140.4 million in 2023, then grew by 16.81% to $164.0 million in 2024, then grew by 21.32% to $199.0 million in 2025, then rose by 8.27% to $215.5 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Shares Outstanding (Weighted Average) are $215.5 million (Q1 2026), $199.0 million (Q4 2025), and $211.8 million (Q3 2025).